Corbus Pharmaceuticals Holdings, Inc. (CRBP) › Capital ExpendituresCorbus Pharmaceuticals Holdings, Inc. (CRBP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $64.4K2015: $114.0K2016: $353.0K2017: $707.4K2018: $2.30M2019: $2.74M2020: $484.5K2021: $54.2K2022: $13.4K2023: $02024: $02025: $7.0K$7.0K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$7.0K—2024$0—2023$0-100.0%2022$13.4K-75.2%2021$54.2K-88.8%2020$484.5K-82.3%2019$2.74M+19.2%2018$2.30M+225.2%2017$707.4K+100.4%2016$353.0K+209.6%2015$114.0K+76.9%2014$64.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share